Recent Bills
- H.R. 10171August 27, 2026
- H.R. 10156August 27, 2026
- H.R. 10172August 27, 2026
- H.R. 10160August 27, 2026
- H.R. 10181August 27, 2026
- H.R. 10176August 27, 2026
- H.Res. 1496August 27, 2026
- H.R. 10164August 27, 2026
- H.R. 10170August 27, 2026
- H.Res. 1494August 27, 2026
- H.R. 10163August 27, 2026
- H.R. 10157August 27, 2026
Committees
- Administration
- Agriculture
- Agriculture, Nutrition, And Forestry
- Appropriations
- Armed Services
- Banking, Housing, And Urban Affairs
- Budget
- Commerce, Science, And Transportation
- Education and Workforce
- Energy And Commerce
- Energy And Natural Resources
- Environment And Public Works
- Ethics
- Finance
- Financial Services
- Foreign Affairs
- Foreign Relations
- Health, Education, Labor, And Pensions
- Homeland Security
- Homeland Security And Governmental Affa…
- Indian Affairs
- Indian and Insular Affairs
- Intelligence
- Judiciary
- Natural Resources
- Oversight And Government Reform
- Permanent Select Intelligence
- Rules
- Rules And Administration
- Science, Space, And Technology
- Select Intelligence
- Small Business
- Small Business And Entrepreneurship
- Subcommittee on Aviation
- Subcommittee on Border Security and Enf…
- Subcommittee on Coast Guard and Maritim…
- Subcommittee on Commodity Markets, Digi…
- Subcommittee on Conservation, Research,…
- Subcommittee on Counterterrorism and In…
- Subcommittee on Cybersecurity and Infra…
- Subcommittee on Disability Assistance a…
- Subcommittee on Economic Development, P…
- Subcommittee on Economic Opportunity
- Subcommittee on Emergency Management an…
- Subcommittee on Energy and Mineral Reso…
- Subcommittee on Federal Lands
- Subcommittee on Forestry and Horticultu…
- Subcommittee on General Farm Commoditie…
- Subcommittee on Health
- Subcommittee on Highways and Transit
- Subcommittee on Livestock, Dairy, and P…
- Subcommittee on Nutrition and Foreign A…
- Subcommittee on Oversight and Investiga…
- Subcommittee on Oversight, Investigatio…
- Subcommittee on Railroads, Pipelines, a…
- Subcommittee on Transportation and Mari…
- Subcommittee on Water Resources and Env…
- Subcommittee on Water, Wildlife and Fis…
- Transportation And Infrastructure
- Veterans' Affairs
- Ways And Means
JAMIE GREGORIAN is a registered lobbyist named on 138 federal lobbying filings, 2023 to 2026, reporting $6.8M across them.
An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.
Firms
1 they have filed under, by filings.
| Registrant | Filings | Reported |
|---|---|---|
| DLA PIPER LLP (US) | 138 | $6.8M |
By year
Filings and what they reported, newest year first.
| Year | Filings | Income | Expenses |
|---|---|---|---|
| 2026 | 20 | $970K | — |
| 2025 | 48 | $2.1M | — |
| 2024 | 37 | $1.9M | — |
| 2023 | 33 | $1.8M | — |
Issues
The LDA issue codes the filings were filed under.
| Code | Issue | Filings |
|---|---|---|
HCR | Health Issues | 86 |
PHA | Pharmacy | 32 |
MMM | Medicare/Medicaid | 24 |
MED | Medical/Disease Research/Clinical Labs | 9 |
AUT | Automotive Industry | 4 |
ENG | Energy/Nuclear | 4 |
TAX | Taxation/Internal Revenue Code | 4 |
DEF | Defense | 2 |
GOV | Government Issues | 2 |
CSP | Consumer Issues/Safety/Products | 1 |
VET | Veterans | 1 |
Bills
The bills the filings name, by how many name them.
| Bill | Title | Filings |
|---|---|---|
| H.R. 1262 | Mikaela Naylon Give Kids a Chance Act | 4 |
| H.R. 4231 | Treat and Reduce Obesity Act of 2025 | 4 |
| H.R. 5133 | Patients’ Right to Know Their Medication Act of 2025 | 4 |
| H.R. 946 | ORPHAN Cures Act | 4 |
| S. 1973 | Treat and Reduce Obesity Act of 2025 | 4 |
| S. 932 | Give Kids a Chance Act of 2025 | 4 |
| H.R. 4016 | Department of Defense Appropriations Act, 2026 | 3 |
| H.R. 1 | An act to provide for reconciliation pursuant to title II of H. Con. Res. 14. | 2 |
| H.R. 5376 | Impacts and Outcomes for Health Career Training Act | 2 |
| S. 2572 | Department of Defense Appropriations Act, 2026 | 2 |
Filings
The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.
| Client | Registrant | Period | Reported | Posted |
|---|---|---|---|---|
| IQVIA HOLDINGS, INC. | DLA PIPER LLP (US) | 2026 second_quarter | $60K | Jul 20, 2026 |
| CURRAX PHARMACEUTICALS LLC | DLA PIPER LLP (US) | 2026 second_quarter | $50K | Jul 20, 2026 |
| ONE WORLD TECHNOLOGIES, INC. | DLA PIPER LLP (US) | 2026 second_quarter | $90K | Jul 20, 2026 |
| B. BRAUN MEDICAL INC. | DLA PIPER LLP (US) | 2026 second_quarter | $30K | Jul 20, 2026 |
| AMERIHEALTH CARITAS | DLA PIPER LLP (US) | 2026 second_quarter | $30K | Jul 17, 2026 |
| BIONJ, INC. | DLA PIPER LLP (US) | 2026 second_quarter | $50K | Jul 17, 2026 |
| ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) | DLA PIPER LLP (US) | 2026 second_quarter | $60K | Jul 17, 2026 |
| BIOTECHNOLOGY INNOVATION ORGANIZATION | DLA PIPER LLP (US) | 2026 second_quarter | $60K | Jul 17, 2026 |
| CORVENT MEDICAL, INC. | DLA PIPER LLP (US) | 2026 second_quarter | $60K | Jul 17, 2026 |
| XEROX HOLDINGS CORPORATION | DLA PIPER LLP (US) | 2026 second_quarter | $60K | Jul 17, 2026 |
| ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) | DLA PIPER LLP (US) | 2026 first_quarter | $60K | Apr 20, 2026 |
| BIOTECHNOLOGY INNOVATION ORGANIZATION | DLA PIPER LLP (US) | 2026 first_quarter | $60K | Apr 20, 2026 |
| CURRAX PHARMACEUTICALS LLC | DLA PIPER LLP (US) | 2026 first_quarter | $50K | Apr 20, 2026 |
| IQVIA HOLDINGS, INC. | DLA PIPER LLP (US) | 2026 first_quarter | $60K | Apr 20, 2026 |
| CORVENT MEDICAL, INC. | DLA PIPER LLP (US) | 2026 first_quarter | $20K | Apr 20, 2026 |
| XEROX HOLDINGS CORPORATION | DLA PIPER LLP (US) | 2026 first_quarter | $60K | Apr 20, 2026 |
| B. BRAUN MEDICAL INC. | DLA PIPER LLP (US) | 2026 first_quarter | $30K | Apr 17, 2026 |
| BIONJ, INC. | DLA PIPER LLP (US) | 2026 first_quarter | $50K | Apr 17, 2026 |
| AMERIHEALTH CARITAS | DLA PIPER LLP (US) | 2026 first_quarter | $30K | Apr 17, 2026 |
| CORVENT MEDICAL, INC. | DLA PIPER LLP (US) | 2026 first_quarter | — | Mar 31, 2026 |
| BIONJ, INC. | DLA PIPER LLP (US) | 2025 fourth_quarter | $50K | Jan 20, 2026 |
| CURRAX PHARMACEUTICALS LLC | DLA PIPER LLP (US) | 2025 fourth_quarter | $50K | Jan 20, 2026 |
| IQVIA HOLDINGS, INC. | DLA PIPER LLP (US) | 2025 fourth_quarter | $60K | Jan 20, 2026 |
| B. BRAUN MEDICAL INC. | DLA PIPER LLP (US) | 2025 fourth_quarter | $30K | Jan 20, 2026 |
| INTRA-CELLULAR THERAPIES, INC. | DLA PIPER LLP (US) | 2025 fourth_quarter | $50K | Jan 16, 2026 |